Publisher Correction : Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial
Errataetall: |
ErratumFor: Nat Med. 2022 Oct;28(10):2183-2193. - PMID 35941373 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Nature medicine - 30(2024), 2 vom: 22. Feb., Seite 606 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Feigin, Andrew [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 23.02.2024 published: Print ErratumFor: Nat Med. 2022 Oct;28(10):2183-2193. - PMID 35941373 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1038/s41591-022-02070-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM347111106 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM347111106 | ||
003 | DE-627 | ||
005 | 20240229143559.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41591-022-02070-0 |2 doi | |
028 | 5 | 2 | |a pubmed24n1303.xml |
035 | |a (DE-627)NLM347111106 | ||
035 | |a (NLM)36195687 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Feigin, Andrew |e verfasserin |4 aut | |
245 | 1 | 0 | |a Publisher Correction |b Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 23.02.2024 | ||
500 | |a published: Print | ||
500 | |a ErratumFor: Nat Med. 2022 Oct;28(10):2183-2193. - PMID 35941373 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Published Erratum | |
700 | 1 | |a Evans, Elizabeth E |e verfasserin |4 aut | |
700 | 1 | |a Fisher, Terrence L |e verfasserin |4 aut | |
700 | 1 | |a Leonard, John E |e verfasserin |4 aut | |
700 | 1 | |a Smith, Ernest S |e verfasserin |4 aut | |
700 | 1 | |a Reader, Alisha |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Vikas |e verfasserin |4 aut | |
700 | 1 | |a Manber, Richard |e verfasserin |4 aut | |
700 | 1 | |a Walters, Kimberly A |e verfasserin |4 aut | |
700 | 1 | |a Kowarski, Lisa |e verfasserin |4 aut | |
700 | 1 | |a Oakes, David |e verfasserin |4 aut | |
700 | 1 | |a Siemers, Eric |e verfasserin |4 aut | |
700 | 1 | |a Kieburtz, Karl D |e verfasserin |4 aut | |
700 | 1 | |a Zauderer, Maurice |e verfasserin |4 aut | |
700 | 0 | |a Huntington Study Group SIGNAL investigators |e verfasserin |4 aut | |
700 | 1 | |a Kayson, Elise |e investigator |4 oth | |
700 | 1 | |a Goldstein, Jody |e investigator |4 oth | |
700 | 1 | |a Barbano, Richard |e investigator |4 oth | |
700 | 1 | |a Marder, Karen |e investigator |4 oth | |
700 | 1 | |a Dayalu, Praveen |e investigator |4 oth | |
700 | 1 | |a Rosas, Herminia Diana |e investigator |4 oth | |
700 | 1 | |a Kostyk, Sandra |e investigator |4 oth | |
700 | 1 | |a Kamholz, John |e investigator |4 oth | |
700 | 1 | |a Racette, Brad |e investigator |4 oth | |
700 | 1 | |a Bang, Jee |e investigator |4 oth | |
700 | 1 | |a Claassen, Daniel |e investigator |4 oth | |
700 | 1 | |a McDonell, Katherine |e investigator |4 oth | |
700 | 1 | |a Factor, Stewart |e investigator |4 oth | |
700 | 1 | |a Walker, Francis |e investigator |4 oth | |
700 | 1 | |a Goas, Clarisse |e investigator |4 oth | |
700 | 1 | |a Wojcieszek, Joanne |e investigator |4 oth | |
700 | 1 | |a Raymond, Lynn A |e investigator |4 oth | |
700 | 1 | |a Corey-Bloom, Jody |e investigator |4 oth | |
700 | 1 | |a Sung, Victor |e investigator |4 oth | |
700 | 1 | |a Dean, Marissa |e investigator |4 oth | |
700 | 1 | |a Geshwind, Michael |e investigator |4 oth | |
700 | 1 | |a Nelson, Alexandra |e investigator |4 oth | |
700 | 1 | |a Frank, Samuel |e investigator |4 oth | |
700 | 1 | |a LaFaver, Kathrin |e investigator |4 oth | |
700 | 1 | |a Duker, Andrew |e investigator |4 oth | |
700 | 1 | |a Elmer, Lawrence |e investigator |4 oth | |
700 | 1 | |a Samii, Ali |e investigator |4 oth | |
700 | 1 | |a Lin, Yi-Han |e investigator |4 oth | |
700 | 1 | |a Chouinard, Sylvain |e investigator |4 oth | |
700 | 1 | |a Seeberger, Lauren |e investigator |4 oth | |
700 | 1 | |a Scott, Burton |e investigator |4 oth | |
700 | 1 | |a Boyd, James |e investigator |4 oth | |
700 | 1 | |a McFarland, Nikolaus |e investigator |4 oth | |
700 | 1 | |a Stimming, Erin Furr |e investigator |4 oth | |
700 | 1 | |a Suchowersky, Oksana |e investigator |4 oth | |
700 | 1 | |a Testa, Claudia |e investigator |4 oth | |
700 | 1 | |a Anderson, Karen |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Nature medicine |d 1995 |g 30(2024), 2 vom: 22. Feb., Seite 606 |w (DE-627)NLM074659804 |x 1546-170X |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2024 |g number:2 |g day:22 |g month:02 |g pages:606 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41591-022-02070-0 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2024 |e 2 |b 22 |c 02 |h 606 |